Gene · 6921
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors. | Med Sci (Basel) | 2023 | 37489462 | PubTator, text mining | PubMed |
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy. | Cell Mol Life Sci | 2023 | 37477829 | PubTator, text mining | PubMed |
| Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors. | J Clin Med | 2023 | 37445575 | PubTator, text mining | PubMed |
| Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation. | Nat Commun | 2023 | 37443112 | PubTator, text mining | PubMed |
| Disrupted topological organization of white matter structural networks in high myopia patients revealed by diffusion kurtosis imaging and tractography. | Front Neurosci | 2023 | 37425009 | PubTator, text mining | PubMed |
| Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G. | Nat Commun | 2023 | 37419875 | PubTator, text mining | PubMed |
| The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. | Sci Rep | 2023 | 37400554 | PubTator, text mining | PubMed |
| Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation. | Nat Cell Biol | 2023 | 37400498 | PubTator, text mining | PubMed |
| Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing. | Genes (Basel) | 2023 | 37372372 | PubTator, text mining | PubMed |
| Clinical Characteristics of Molecularly Defined Renal Cell Carcinomas. | Curr Issues Mol Biol | 2023 | 37367052 | PubTator, text mining | PubMed |
| The pyridazine heterocycle in molecular recognition and drug discovery. | Med Chem Res | 2023 | 37362319 | PubTator, text mining | PubMed |
| Assembly and disassembly of branched ubiquitin chains. | Front Mol Biosci | 2023 | 37325469 | PubTator, text mining | PubMed |
| Rational screening for cooperativity in small-molecule inducers of protein-protein associations. | bioRxiv | 2023 | 37292909 | PubTator, text mining | PubMed |
| PROTACs: A novel strategy for cancer drug discovery and development. | MedComm (2020) | 2023 | 37261210 | PubTator, text mining | PubMed |
| Recent Advances in Covalent Drug Discovery. | Pharmaceuticals (Basel) | 2023 | 37242447 | PubTator, text mining | PubMed |
| Current Knowledge and Prospects for Renal Hemangioblastoma and Renal Cell Carcinoma with Hemangioblastoma-like Features. | Biomedicines | 2023 | 37239138 | PubTator, text mining | PubMed |
| Cystic Diseases of the Kidneys: From Bench to Bedside. | Indian J Nephrol | 2023 | 37234435 | PubTator, text mining | PubMed |
| In silico analysis of the profilaggrin sequence indicates alterations in the stability, degradation route, and intracellular protein fate in filaggrin null mutation carriers. | Front Mol Biosci | 2023 | 37200867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/papers?page=8